1. Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells
    Yujin Lee et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  2. Luteolin, a flavonoid, as an anticancer agent: A review
    Muhammad Imran et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  3. Screening, characterization, and in vitro-ROS dependent cytotoxic potential of extract from Ficus carica against hepatocellular (HepG2) carcinoma cells
    Kiren Mustafa et al, 2021, South African Journal of Botany CrossRef
  4. Crosstalk between xanthine oxidase (XO) inhibiting and cancer chemotherapeutic properties of comestible flavonoids- a comprehensive update
    Md Sohanur Rahaman et al, 2022, The Journal of Nutritional Biochemistry CrossRef
  5. From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders
    Md Sadique Hussain et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
  6. Synergistic Combination of Luteolin and Asiatic Acid on Cervical Cancer In Vitro and In Vivo
    Ya-Hui Chen et al, 2023, Cancers CrossRef
  7. Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation
    Uddin Nazim et al, 2018, International Journal of Oncology CrossRef
  8. Study of synergistic effects of Ficus Carica leaves extract mediated chemo-photodynamic therapy on rhabdomyosarcoma cells
    Bushra Aziz et al, 2021, Photodiagnosis and Photodynamic Therapy CrossRef
  9. Green synthesis of chicory (Cichorium intybus L.) Chitosan nanoparticles and evaluation of their anti-fungal, anti-hemolytic, and anti-cancer activities
    Muobarak Tuorkey et al, 2022, Journal of Bioactive and Compatible Polymers CrossRef
  10. Anticancer Activity of Methanol Extract of Ficus carica Leaves and Fruits Against Proliferation, Apoptosis, and Necrosis in Huh7it Cells
    Risa Purnamasari et al, 2019, Cancer Informatics CrossRef
  11. Analysis of proautophagic activities of Citrus flavonoids in liver cells reveals the superiority of a natural polyphenol mixture over pure flavones
    Antonella Lascala et al, 2018, The Journal of Nutritional Biochemistry CrossRef
  12. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology
    Bao-Jun Liu et al, 2024, Journal of Ethnopharmacology CrossRef
  13. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (Codonopsis pilosula) Against Hepatocellular Carcinoma: Validation Based on the Active Compound Luteolin
    Yaping Yu et al, 2023, Drug Design, Development and Therapy CrossRef
  14. 2-(Naphthalene-2-thio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK, AKT, and STAT3 signaling pathways in HepG2 human hepatocellular carcinoma cells
    Yang Liu et al, 2022, Drug and Chemical Toxicology CrossRef
  15. Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of Codonopsis pilosula against Hepatocellular Carcinoma
    Zhili Liu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  16. Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma
    Mingming Fan et al, 2017, Oncology Reports CrossRef
  17. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated
    Shabir Ahmad Ganai et al, 2021, Phytotherapy Research CrossRef
  18. Luteolin-induced apoptosis through activation of endoplasmic reticulum stress sensors in pheochromocytoma cells
    Kisang Kwon et al, 2017, Molecular Medicine Reports CrossRef
  19. Flavonoids in cancer therapy: current and future trends
    Sevim Beyza Gürler et al, 2020, Biodiversity and Biomedicine CrossRef
  20. Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species
    Weimin Dong et al, 2018, International Journal of Molecular Medicine CrossRef
  21. Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma
    Hsiang-Chun Lai et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
  22. Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
    Chenhao Yao et al, 2023, Biomedicine & Pharmacotherapy CrossRef